KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Change in Cash: 2009-2024

Historic Change in Cash for Arbutus Biopharma (ABUS) over the last 16 years, with Dec 2024 value amounting to $10.0 million.

  • Arbutus Biopharma's Change in Cash rose 51.51% to -$15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.4 million, marking a year-over-year decrease of 165.93%. This contributed to the annual value of $10.0 million for FY2024, which is 323.67% up from last year.
  • Arbutus Biopharma's Change in Cash amounted to $10.0 million in FY2024, which was up 323.67% from -$4.5 million recorded in FY2023.
  • Over the past 5 years, Arbutus Biopharma's Change in Cash peaked at $57.0 million during FY2021, and registered a low of -$78.5 million during FY2022.
  • Its 3-year average for Change in Cash is -$24.3 million, with a median of -$4.5 million in 2023.
  • In the last 5 years, Arbutus Biopharma's Change in Cash soared by 497.67% in 2020 and then slumped by 237.65% in 2022.
  • Arbutus Biopharma's Change in Cash (Yearly) stood at $20.5 million in 2020, then spiked by 178.85% to $57.0 million in 2021, then tumbled by 237.65% to -$78.5 million in 2022, then spiked by 94.28% to -$4.5 million in 2023, then skyrocketed by 323.67% to $10.0 million in 2024.